GreenLight Biosciences is using a proprietary cell-free RNA production technology to develop RNA-based products for the agricultural market.
HitGen will apply its DNA-encoded library design, synthesis, and screening platform to discover novel leads for Bayer research endeavors.
In PLOS this week: sequencing of Chardonnay clones, high-density peach tree genetic map, and more.
The firm's technology uses DNA sequencing, artificial intelligence, and a microbial database to interpret soil health and identify potential disease risk.
Researchers demonstrate the potential of CRISPR gene editing to prevent disease among livestock, Discover's D-brief blog reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
The Boston-based synthetic biology company will use the proceeds to grow Bioworks3, its new organism foundry, and to expand into new markets.
ExcitePCR's technology detects pathogens in 30 minutes or less using a backpack-sized device, integrating sample prep with PCR and RIF technology in a disposable cartridge.
The yet-to-be-named entity will draw on the partners' respective resources in synthetic biology and plant and agricultural products.
The proceeds from the seed round will enable TL Biolabs to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.
Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.
Wired reports that researchers have shown they could reprogram a DNA-based computer.
Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.
In Science this week: whole-genome sequencing of single sperm cells, and more.